Real-World Experience with<sup>177</sup>Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Experience with¹⁷⁷Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval

Published:2024-03-14 Issue:5 Volume:65 Page:735-739
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Moradi Tuchayi Abuzar,Yadav Surekha,Jiang Fei,Kim Sarasa T.,Saelee Rachelle K.,Morley Amanda,Juarez Roxanna,Lawhn-Heath Courtney,Wang Yingbing,de Kouchkovsky Ivan,Hope Thomas A.

Publisher

Society of Nuclear Medicine

Reference14 articles.

1. Metastatic Prostate Cancer

2. Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

3. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

4. Prostate-specific membrane antigen (PSMA)-targeted radionuclide therapies for prostate cancer;Sun;Curr Oncol Rep.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?;Expert Review of Anticancer Therapy;2024-08-29

2. Impact of Posttreatment SPECT/CT on Patient Management During¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy;Journal of Nuclear Medicine;2024-08-08

3. Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression;Journal of Nuclear Medicine;2024-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP